Carsten Tschöpe Selected Research

Angiotensin II

12/2016	Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
11/2012	Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
5/2012	Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
1/2007	The role of the renal kallikrein-kinin system in diabetic nephropathy.
1/2005	Angiotensin AT2 receptor deficiency after myocardial infarction: its effects on cardiac function and fibrosis depend on the stimulus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carsten Tschöpe Research Topics

Disease

61	Heart Failure 01/2022 - 08/2002
47	Inflammation (Inflammations) 01/2022 - 12/2005
35	Myocarditis (Carditis) 01/2022 - 05/2004
33	Fibrosis (Cirrhosis) 01/2021 - 11/2003
25	Cardiomyopathies (Cardiomyopathy) 04/2022 - 12/2002
20	Infections 01/2022 - 05/2004
18	Diabetic Cardiomyopathies 01/2021 - 10/2002
16	Myocardial Infarction 01/2021 - 08/2002
10	Left Ventricular Dysfunction 11/2012 - 08/2002
9	Hypertension (High Blood Pressure) 01/2019 - 12/2002
9	Diabetes Mellitus 07/2013 - 12/2002
8	Heart Diseases (Heart Disease) 01/2022 - 01/2007
8	Cardiogenic Shock 11/2021 - 01/2019
7	Infarction (Infarctions) 01/2021 - 03/2006
7	Cardiomegaly (Heart Hypertrophy) 11/2012 - 03/2006
6	Amyloidosis 06/2022 - 01/2021
6	Virus Diseases (Viral Diseases) 12/2020 - 07/2008
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2019 - 06/2004
5	Body Weight (Weight, Body) 01/2022 - 11/2007
5	Cardiotoxicity 01/2021 - 11/2007
5	Diastolic Heart Failure 01/2020 - 03/2006
5	Hyperglycemia 12/2017 - 12/2002
5	Ischemia 01/2016 - 12/2002
4	Disease Progression 01/2022 - 04/2010
4	COVID-19 11/2021 - 10/2020
4	Atrial Fibrillation 11/2021 - 10/2007
4	Cicatrix (Scar) 11/2019 - 12/2009
4	Hypertrophy 01/2018 - 09/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 08/2008
3	Acute Coronary Syndrome 04/2022 - 11/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2010
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 03/2006
3	Takotsubo Cardiomyopathy 03/2020 - 01/2020
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2010 - 11/2006
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2008 - 03/2003
2	Polyneuropathies (Polyneuropathy) 06/2022 - 04/2022
2	Amyloid Plaque 04/2022 - 04/2021
2	Necrosis 01/2022 - 10/2018
2	Neoplasms (Cancer) 01/2021 - 09/2011

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2008
17	CollagenIBA 01/2021 - 11/2006
14	Streptozocin (Streptozotocin)FDA Link 01/2020 - 03/2003
13	CytokinesIBA 01/2021 - 05/2004
11	Messenger RNA (mRNA)IBA 10/2018 - 12/2002
8	Pharmaceutical PreparationsIBA 01/2022 - 11/2007
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 05/2011
8	Antiviral Agents (Antivirals)IBA 12/2020 - 10/2008
8	KininsIBA 04/2010 - 12/2002
6	AngiotensinsIBA 01/2017 - 06/2004
6	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011 - 11/2007
5	Prealbumin (Transthyretin)IBA 06/2022 - 04/2021
5	adenovirus receptorIBA 11/2019 - 04/2009
5	ConnectinIBA 01/2017 - 09/2009
5	Angiotensin IIIBA 12/2016 - 01/2005
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015 - 08/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 11/2007
5	BradykininIBA 01/2007 - 08/2002
4	InterferonsIBA 12/2020 - 01/2014
4	AldosteroneIBA 10/2020 - 02/2013
4	Simendan (Levosimendan)IBA 03/2020 - 01/2018
4	Natriuretic PeptidesIBA 01/2020 - 10/2007
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 07/2013
4	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 06/2005
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016 - 03/2008
4	HDL LipoproteinsIBA 01/2016 - 03/2008
4	HDL CholesterolIBA 01/2016 - 04/2009
4	Interleukin-6 (Interleukin 6)IBA 01/2014 - 04/2009
4	Matrix Metalloproteinases (MMPs)IBA 11/2011 - 03/2007
4	Tissue Kallikreins (Tissue Kallikrein)IBA 02/2008 - 05/2004
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2021 - 01/2014
3	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 10/2019 - 07/2013
3	ApolipoproteinsIBA 10/2019 - 03/2008
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 06/2005
3	CalciumIBA 01/2018 - 06/2008
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 02/2013
3	DiureticsIBA 01/2018 - 12/2010
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 01/2007
3	ReninIBA 01/2017 - 01/2007
3	Angiotensin Receptor AntagonistsIBA 04/2015 - 01/2008
3	ChemokinesIBA 01/2014 - 06/2009
3	Irbesartan FDA LinkGeneric 11/2012 - 02/2004
3	Peptides (Polypeptides)IBA 04/2010 - 06/2004
3	aliskiren FDA Link 01/2010 - 06/2008
3	Kallikreins (Kallikrein)IBA 02/2008 - 07/2003
2	Monoclonal AntibodiesIBA 04/2022 - 11/2007
2	SteroidsIBA 01/2022 - 09/2019
2	InflammasomesIBA 01/2022 - 12/2018
2	Troponin T (Troponin T1)IBA 11/2021 - 03/2006
2	3-nitrotyrosineIBA 06/2021 - 01/2009
2	empagliflozinIBA 01/2021 - 12/2018
2	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2020
2	Mineralocorticoid Receptor AntagonistsIBA 10/2020 - 04/2015

Therapy/Procedure

39	Therapeutics 04/2022 - 08/2002
10	Catheters 01/2022 - 11/2006
4	Immunomodulation 12/2019 - 03/2010
3	Extracorporeal Membrane Oxygenation 01/2021 - 01/2019
2	Heart-Assist Devices 11/2021 - 10/2020
2	Defibrillators (Defibrillator) 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
2	Percutaneous Coronary Intervention 01/2021 - 10/2017